Skip to content

Ingevity

US · NGVT #2634 by market cap Listed 1970
70.92 -1.88 -2.58%
Live - 5344 symbols - heartbeat 53s ago · 2026-10-07 20:02
After-hours 70.92 0.00%
Market cap
2.44B
P/B
51.99
EPS
-4.61
Reader sentiment Are you bullish or bearish on NGVT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
  • Total institutional ownership rose 0.3 percentage points.

Institutional ownership

Held by institutions
103.10% +0.32pp
Institutions
373 -1
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund84.52%
Hedge Fund12.84%
Government Pension Fund2.36%
Public Company2.10%
Individual/Insider0.92%
Private Company0.54%
Family Office/Trust0.27%
Insurance Company0.18%
Sovereign Wealth Fund0.18%

Top holders

BlackRock 15.60%
Vanguard Portfolio Management, LLC 6.91%
Vanguard Capital Management, LLC 5.30%
State Street Global Advisors 4.36%
American Century Investment Management 3.70%
Wellington Management Group 3.13%
Segall Bryant & Hamill, LLC 3.07%
Millennium Management LLC 3.03%
Brown Advisory Incorporated 2.83%
Royce & Associates, LP 2.74%

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 29 buys · 21 sells

NameRoleStake
John Fortson Chief Executive Officer 0.26%
Luis Fernandez-Moreno Independent Director 0.09%
Mary Hall Chief Financial Officer 0.08%
Frederick Lynch Independent Director 0.06%
Jean Blackwell Independent Chairperson 0.06%
Phillip Platt VP, Chief Accounting Officer & Business Transformation Lead 0.05%
Ryan Fisher Former Interim General Counsel & Secretary 0.05%
Stuart Woodcock Executive VP & President of Performance Materials 0.05%
Daniel Sansone Independent Director 0.04%
Diane Gulyas Independent Director 0.04%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 John Willis Independent Director Other Acquisition +405 $71.09
2026-09-30 F. Segal Director Other Acquisition +335 $71.09
2026-08-17 David Li Chief Executive Officer Open Market Disposition -10,092 $74.71–75.83
2026-08-12 David Li Chief Executive Officer Open Market Disposition -10,000 $75.73–76.62
2026-08-11 David Li Chief Executive Officer Intent to Sell (Form 144) -20,092 $77.79
2026-08-09 Phillip Platt VP, Chief Accounting Officer & Business Transformation Lead Sale to Issuer -1,698 $77.04
2026-08-02 Ryan Fisher Former Interim General Counsel & Secretary Open Market Disposition -2,709 $73.67–73.76
2026-07-23 Phillip Platt VP, Chief Accounting Officer & Business Transformation Lead Sale to Issuer -3,294 $73.26
2026-07-05 Ryan Fisher Former Interim General Counsel & Secretary Sale to Issuer -168 $73.86
2026-06-30 John Willis Independent Director Other Acquisition +397 $72.58
2026-06-30 F. Segal Director Other Acquisition +328 $72.58
2026-06-21 Ryan Cotterman Vice President, Chief Accounting Officer & Principal Accounting Officer Other Acquisition +2,063 --
2026-05-27 Terrance Dyer Chief Human Resources Officer Open Market Disposition -496 $68.45–68.57
2026-04-30 Phillip Platt VP, Chief Accounting Officer & Business Transformation Lead Other Acquisition +1,262 --
2026-04-29 Karen Narwold Independent Director Other Acquisition +1,904 --
2026-04-29 Luis Fernandez-Moreno Independent Director Other Acquisition +1,904 --
2026-04-29 Frederick Lynch Independent Director Other Acquisition +1,904 --
2026-04-29 John Willis Independent Director Other Acquisition +1,904 --
2026-04-29 Diane Gulyas Independent Director Other Acquisition +1,904 --
2026-04-29 F. Segal Director Other Acquisition +1,904 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 20:02:22 · For reference only, not investment advice and not tailored to your situation.